• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Immune Netw . The Progression of SARS Coronavirus 2 (SARS-CoV2): Mutation in the Receptor Binding Domain of Spike Gene

tetano

Editor, Senior Moderator
Immune Netw


. 2020 Oct 26;20(5):e41.
doi: 10.4110/in.2020.20.e41. eCollection 2020 Oct.
The Progression of SARS Coronavirus 2 (SARS-CoV2): Mutation in the Receptor Binding Domain of Spike Gene


Sinae Kim[SUP] 1 2 [/SUP], Jong Ho Lee[SUP] 3 [/SUP], Siyoung Lee[SUP] 1 4 [/SUP], Saerok Shim[SUP] 1 [/SUP], Tam T Nguyen[SUP] 1 2 [/SUP], Jihyeong Hwang[SUP] 1 [/SUP], Heijun Kim[SUP] 1 [/SUP], Yeo-Ok Choi[SUP] 1 [/SUP], Jaewoo Hong[SUP] 1 2 [/SUP], Suyoung Bae[SUP] 1 5 [/SUP], Hyunjhung Jhun[SUP] 1 6 [/SUP], Hokee Yum[SUP] 7 [/SUP], Youngmin Lee[SUP] 8 [/SUP], Edward D Chan[SUP] 9 [/SUP], Liping Yu[SUP] 10 [/SUP], Tania Azam[SUP] 11 [/SUP], Yong-Dae Kim[SUP] 12 [/SUP], Su Cheong Yeom[SUP] 13 [/SUP], Kwang Ha Yoo[SUP] 14 [/SUP], Lin-Woo Kang[SUP] 15 [/SUP], Kyeong-Cheol Shin[SUP] 16 [/SUP], Soohyun Kim[SUP] 1 2 17 [/SUP]



Affiliations

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) is a positive-sense single-stranded RNA (+ssRNA) that causes coronavirus disease 2019 (COVID-19). The viral genome encodes twelve genes for viral replication and infection. The third open reading frame is the spike (S) gene that encodes for the spike glycoprotein interacting with specific cell surface receptor - angiotensin converting enzyme 2 (ACE2) - on the host cell membrane. Most recent studies identified a single point mutation in S gene. A single point mutation in S gene leading to an amino acid substitution at codon 614 from an aspartic acid 614 into glycine (D614G) resulted in greater infectivity compared to the wild type SARS-CoV2. We were interested in investigating the mutation region of S gene of SARS-CoV2 from Korean COVID-19 patients. New mutation sites were found in the critical receptor binding domain (RBD) of S gene, which is adjacent to the aforementioned D614G mutation residue. This specific sequence data demonstrated the active progression of SARS-CoV2 by mutations in the RBD of S gene. The sequence information of new mutations is critical to the development of recombinant SARS-CoV2 spike antigens, which may be required to improve and advance the strategy against a wide range of possible SARS-CoV2 mutations.

Keywords: COVID-19 antigens; COVID-19 mutation; COVID-19 receptor binding domain; SARS coronavirus 2; Spike glycoprotein.
 
Back
Top Bottom